YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Sun Pharma Adv
Sun Pharma Adv
BSE: 532872NSE: SPARCISIN: INE232I01014

9th-May-2021 14:07Source: BSE

Sun Pharma Advanced Research Company - Board Meeting Intimation for Notice Of Board Meeting For Consideration Of Audited Results Of The Company For The Quarter And Financial Year Ended 31St March 2021

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2021 ,inter alia, to consider and approve Pursuant to regulation 29 (1) of the SEBI (Listing obligation & Disclosure Requirements) Regulation, 2015, we hereby inform you that a meeting of the Board of Directors of Sun Pharma Advanced Research Company Limited will be held on Monday, 17th May 2021, inter alia, to consider and approve, the audited financial results of the Company for the quarter and financial year ended 31st March 2021.
Further, kindly note that pursuant to the Company's Code of Conduct for Prevention of Insider Trading, the trading window for trading by designated persons, shall remain closed upto 48 hours after the declaration of financial results of the Company on 17th May 2021.

More Announcements on:

1 2 3 Next >>
Sections